Erica N Peters1, Charla Nich, Kathleen M Carroll. 1. Yale University School of Medicine, Department of Psychiatry, One Long Wharf Drive, Box 18, New Haven, CT 06511, USA. erica.peters@yale.edu
Abstract
BACKGROUND: While several randomized controlled trials evaluating a range of treatments for cannabis use disorders have appeared in recent years, these have been marked by inconsistency in selection of primary outcomes, making it difficult to compare outcomes across studies. METHOD: With the aim of identifying meaningful and reliable outcome domains in treatment studies of cannabis use disorders, we evaluated multiple indicators of marijuana use, marijuana problems, and psychosocial functioning from two independent randomized controlled trials of behavioral treatments for cannabis use disorders (Ns=450 and 136). RESULTS: Confirmatory factor analysis indicated that the best-fitting model of outcomes in both trials encompassed three distinct factors: frequency of marijuana use, severity of marijuana use, and psychosocial functioning. In both trials, frequency of marijuana use and longest period of abstinence during treatment were most strongly associated with outcome during follow-up. Using two categorical definitions of "clinically significant improvement," individuals who demonstrated improvement differed on most end-of-treatment and long-term outcomes from those who did not improve. CONCLUSIONS: Results may guide future randomized controlled trials of treatments for cannabis use disorders in the collection of relevant end-of-treatment outcomes and encourage consistency in the reporting of outcomes across trials.
RCT Entities:
BACKGROUND: While several randomized controlled trials evaluating a range of treatments for cannabis use disorders have appeared in recent years, these have been marked by inconsistency in selection of primary outcomes, making it difficult to compare outcomes across studies. METHOD: With the aim of identifying meaningful and reliable outcome domains in treatment studies of cannabis use disorders, we evaluated multiple indicators of marijuana use, marijuana problems, and psychosocial functioning from two independent randomized controlled trials of behavioral treatments for cannabis use disorders (Ns=450 and 136). RESULTS: Confirmatory factor analysis indicated that the best-fitting model of outcomes in both trials encompassed three distinct factors: frequency of marijuana use, severity of marijuana use, and psychosocial functioning. In both trials, frequency of marijuana use and longest period of abstinence during treatment were most strongly associated with outcome during follow-up. Using two categorical definitions of "clinically significant improvement," individuals who demonstrated improvement differed on most end-of-treatment and long-term outcomes from those who did not improve. CONCLUSIONS: Results may guide future randomized controlled trials of treatments for cannabis use disorders in the collection of relevant end-of-treatment outcomes and encourage consistency in the reporting of outcomes across trials.
Authors: S T Higgins; D D Delaney; A J Budney; W K Bickel; J R Hughes; F Foerg; J W Fenwick Journal: Am J Psychiatry Date: 1991-09 Impact factor: 18.112
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Kathleen M Carroll; Charla Nich; Donna M Lapaglia; Erica N Peters; Caroline J Easton; Nancy M Petry Journal: Addiction Date: 2012-05-08 Impact factor: 6.526
Authors: Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey Journal: Drug Alcohol Depend Date: 2018-11-15 Impact factor: 4.492
Authors: Hedy Kober; Elise E DeVito; Cameron M DeLeone; Kathleen M Carroll; Marc N Potenza Journal: Neuropsychopharmacology Date: 2014-04-07 Impact factor: 7.853
Authors: Samantha G Farris; Jane Metrik; Marcel O Bonn-Miller; Christopher W Kahler; Michael J Zvolensky Journal: J Stud Alcohol Drugs Date: 2016-11 Impact factor: 2.582
Authors: Tae Woo Park; Debbie M Cheng; Christine A Lloyd-Travaglini; Judith Bernstein; Tibor P Palfai; Richard Saitz Journal: Addiction Date: 2015-09 Impact factor: 6.526
Authors: Benjamin Rolland; Fabien D'Hondt; Solène Montègue; Mélanie Brion; Eric Peyron; Julia D'Aviau de Ternay; Philippe de Timary; Mikaïl Nourredine; Pierre Maurage Journal: Neuropsychol Rev Date: 2019-01-03 Impact factor: 7.444
Authors: Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball Journal: Drug Alcohol Depend Date: 2014-01-31 Impact factor: 4.492
Authors: Melissa M Norberg; Robert A Battisti; Jan Copeland; Daniel F Hermens; Ian B Hickie Journal: Int J Ment Health Addict Date: 2012-03-28 Impact factor: 3.836